Literature DB >> 2836516

Human melanoma cells: functional modulation by calciotropic hormones.

R S Mason1, A M Pryke, M Ranson, H E Thomas, S Posen.   

Abstract

Four human melanoma cell lines were examined for their responsiveness to the hormones 1,25-dihydroxyvitamin D3 (1,25[OH]2D3), calcitonin, and parathyroid hormone (1-34). Cells from each of the 4 lines contained high affinity binding sites for 1,25(OH)2D3. At high cell densities, binding of 1,25(OH)2D3 was diminished due to a decrease in receptor number with no apparent change in affinity. Preincubation with 1,25(OH)2D3 (10(-10) to 10(-8) M) increased tyrosinase activity 1.3- to 3.2-fold and 25-hydroxyvitamin D3-24-hydroxylase activity 1.4- to 10-fold. Human calcitonin (0.82 to 82.5 ng/well) raised the intracellular concentration of cyclic adenosine monophosphate 1.4- to 9.4-fold. Tyrosinase activity increased in response to calcitonin in 2 of the cell lines, decreased in the third, and showed no change in the fourth. Human parathyroid hormone (1-34) in concentrations of 1 to 10 ng/ml produced no significant changes in cyclic adenosine monophosphate accumulation, cell numbers, or tyrosinase activity in any of the cell lines. This study indicates that the phenotype of human melanoma cells can be modulated by the calciotropic hormones 1,25(OH)2D3 and calcitonin.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2836516     DOI: 10.1111/1523-1747.ep12462072

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  5 in total

1.  Sun exposure, vitamin D receptor polymorphisms FokI and BsmI and risk of multiple primary melanoma.

Authors:  Rochelle Mandelcorn-Monson; Loraine Marrett; Anne Kricker; Bruce K Armstrong; Irene Orlow; Chris Goumas; Susan Paine; Stefano Rosso; Nancy Thomas; Robert C Millikan; Jason D Pole; Javier Cotignola; Cheryl Rosen; Peter A Kanetsky; Julia Lee-Taylor; Colin B Begg; Marianne Berwick
Journal:  Cancer Epidemiol       Date:  2011-05-25       Impact factor: 2.984

2.  Hormonal stimulation of tyrosinase activity in human foreskin organ cultures.

Authors:  M Iwata; S Iwata; M A Everett; B B Fuller
Journal:  In Vitro Cell Dev Biol       Date:  1990-06

3.  Vitamin D and melanoma incidence and mortality.

Authors:  Marianne Berwick; Eszter O Erdei
Journal:  Pigment Cell Melanoma Res       Date:  2012-10-24       Impact factor: 4.693

4.  Adjuvant therapy with high dose vitamin D following primary treatment of melanoma at high risk of recurrence: a placebo controlled randomised phase II trial (ANZMTG 02.09 Mel-D).

Authors:  Robyn P M Saw; Bruce K Armstrong; Rebecca S Mason; Rachael L Morton; Kerwin F Shannon; Andrew J Spillane; Jonathan R Stretch; John F Thompson
Journal:  BMC Cancer       Date:  2014-10-24       Impact factor: 4.430

5.  A phase I study of high-dose calcitriol in combination with temozolomide for patients with metastatic melanoma.

Authors:  Erin Pettijohn; Brenda Martone; Alfred Rademaker; Timothy Kuzel
Journal:  J Pers Med       Date:  2014-10-17
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.